In a significant development that underscores the growing influence of artificial intelligence in the field of healthcare, Quibim S.L., a Spanish startup known for its innovative AI-powered medical imaging solutions, has successfully secured $50 million in a Series A funding round. This capital
Artificial intelligence has been proving its utility in numerous fields, with one of the most significant being the medical domain, particularly in lung cancer detection and treatment. AI's deep learning models have been specifically applied to CT imaging for tumor analysis, showcasing the
The medical hyperspectral imaging (HSI) market is on a promising growth trajectory, anticipated to expand at a compound annual growth rate (CAGR) of 13.1% and expected to surpass US$ 1.6 billion by 2032. This growth is driven by the increasing demand for advanced diagnostic tools, technological
Imagine a world where cardiologists can visualize the metabolic processes of the heart in real time, drastically improving the diagnosis and treatment of heart conditions. This scenario is rapidly becoming reality thanks to groundbreaking advancements in medical physics. Cutting-edge imaging
The rapid advancements in artificial intelligence (AI) are fundamentally reshaping a multitude of industries, driven by the powerful capabilities of graphics processing units (GPUs) and neural processing units (NPUs). These technological marvels, initially developed for entirely different purposes,
Artificial intelligence (AI) is transforming medical diagnostics, particularly in the fields of radiology and oncology, fundamentally altering how diseases like cancer are diagnosed and treated. One groundbreaking development in this sphere is the AI tool designed by IDIBAPS-Hospital Clínic
